Alaunos Therapeutics (TCRT) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free TCRT Stock Alerts $1.09 +0.04 (+3.81%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Alaunos Therapeutics Short Interest DataCurrent Short Interest1,450,000 sharesPrevious Short Interest1,470,000 sharesChange Vs. Previous Month-1.36%Dollar Volume Sold Short$1.73 millionShort Interest Ratio23.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares16,010,000 sharesFloat Size13,760,000 sharesShort Percent of Float10.54%Today's Trading Volume12,293 sharesAverage Trading Volume40,728 sharesToday's Volume Vs. Average30% Short Selling Alaunos Therapeutics ? Sign up to receive the latest short interest report for Alaunos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTCRT Short Interest Over TimeTCRT Days to Cover Over TimeTCRT Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Alaunos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,450,000 shares $1.73 million -1.4%10.5%23 $1.19 4/30/20241,470,000 shares $1.85 million +0.7%9.6%20.6 $1.26 4/15/20241,460,000 shares $2.04 million -4.0%9.5%12.5 $1.40 3/31/20241,520,000 shares $2.75 million -1.9%9.9%7.9 $1.81 3/15/20241,550,000 shares $2.65 million -6.1%10.1%6.4 $1.71 2/29/20241,650,000 shares $3.45 million -0.6%10.7%4.6 $2.09 Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,660,000 shares $2.64 million -2.9%10.8%4.3 $1.59 1/31/20241,710,000 shares $4.32 million -7.1%11.2%3.9 $2.53 1/15/202427,530,000 shares $4.45 million +1.9%12.0%4 $0.16 12/31/202327,020,000 shares $1.91 million +20.1%11.8%4.2 $0.07 12/15/202322,500,000 shares $1.02 million -5.0%9.8%4.5 $0.05 11/30/202323,690,000 shares $1.57 million +5.9%10.3%7.1 $0.07 11/15/202322,380,000 shares $1.68 million -6.9%9.7%7.2 $0.08 10/31/202324,040,000 shares $1.92 million +3.8%10.5%7.8 $0.08 10/15/202323,170,000 shares $2.55 million +0.0%10.1%9.8 $0.11 9/30/202323,160,000 shares $3.05 million -2.0%10.1%10.9 $0.13 9/15/202323,630,000 shares $2.98 million -2.7%10.3%11.7 $0.13 8/31/202324,290,000 shares $3.42 million -5.5%10.6%13.4 $0.14 8/15/202325,710,000 shares $3.57 million -1.6%11.2%14.9 $0.14 7/31/202326,140,000 shares $11.30 million +1.2%11.4%49.3 $0.43 7/15/202325,820,000 shares $12.14 million -0.1%11.8%48.4 $0.47 6/30/202325,840,000 shares $13.18 million +1.0%11.8%47.5 $0.51 6/15/202325,580,000 shares $12.28 million +2.5%11.7%45.9 $0.48 5/31/202324,950,000 shares $12.45 million +4.8%11.4%40.3 $0.50 5/15/202323,810,000 shares $15.48 million -0.3%11.0%38.1 $0.65 4/30/202323,880,000 shares $13.61 million +0.4%11.1%38.3 $0.57 4/15/202323,780,000 shares $13.55 million +1.2%11.0%35.9 $0.57 3/31/202323,500,000 shares $14.81 million +1.7%10.9%30.4 $0.63 3/15/202323,110,000 shares $11.50 million -1.9%10.7%24.6 $0.50 2/28/202323,560,000 shares $13.08 million +0.0%10.9%21.6 $0.56 2/15/202323,550,000 shares $15.07 million -2.2%10.9%17.6 $0.64 1/31/202324,090,000 shares $17.79 million -0.4%11.2%16.3 $0.74 1/15/202324,180,000 shares $19.28 million -7.3%11.1%15.7 $0.80 12/30/202226,070,000 shares $16.92 million -5.9%12.0%15.2 $0.65 12/15/202227,690,000 shares $17.05 million -11.5%12.8%14.1 $0.62 11/30/202231,290,000 shares $19.96 million -1.3%14.5%9.4 $0.64 11/15/202231,700,000 shares $32.33 million -1.4%16.2%8.6 $1.02 10/31/202232,160,000 shares $36.98 million +9.4%16.3%8.5 $1.15 10/15/202229,390,000 shares $32.04 million +1.1%14.9%7.5 $1.09 9/30/202229,070,000 shares $50.00 million +3.8%14.9%7.6 $1.72Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details 9/15/202228,000,000 shares $59.08 million -3.6%14.4%6.8 $2.11 8/31/202229,050,000 shares $71.46 million +0.0%14.9%9 $2.46 8/15/202229,040,000 shares $56.63 million -3.7%14.9%9.8 $1.95 7/31/202230,150,000 shares $35.28 million +4.4%15.5%10.1 $1.17 7/15/202228,870,000 shares $38.11 million No Change14.8%8.9 $1.32 TCRT Short Interest - Frequently Asked Questions What is Alaunos Therapeutics' current short interest? Short interest is the volume of Alaunos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,450,000 shares of TCRT short. 10.54% of Alaunos Therapeutics' shares are currently sold short. Learn More on Alaunos Therapeutics' current short interest. What is a good short interest ratio for Alaunos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRT shares currently have a short interest ratio of 23.0. Learn More on Alaunos Therapeutics's short interest ratio. What is a good short interest percentage for Alaunos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.54% of Alaunos Therapeutics' floating shares are currently sold short. Is Alaunos Therapeutics' short interest increasing or decreasing? Alaunos Therapeutics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 1,450,000 shares, a decrease of 1.4% from the previous total of 1,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alaunos Therapeutics' float size? Alaunos Therapeutics currently has issued a total of 16,010,000 shares. Some of Alaunos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alaunos Therapeutics currently has a public float of 13,760,000 shares. How does Alaunos Therapeutics' short interest compare to its competitors? 10.54% of Alaunos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Alaunos Therapeutics: Spruce Biosciences, Inc. (0.30%), Lantern Pharma Inc. (5.50%), MediciNova, Inc. (0.34%), Rallybio Co. (8.08%), Celularity Inc. (5.94%), Eledon Pharmaceuticals, Inc. (0.77%), Affimed (1.77%), Checkpoint Therapeutics, Inc. (12.68%), Immix Biopharma, Inc. (2.38%), Theratechnologies Inc. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Alaunos Therapeutics stock? Short selling TCRT is an investing strategy that aims to generate trading profit from Alaunos Therapeutics as its price is falling. TCRT shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alaunos Therapeutics? A short squeeze for Alaunos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRT, which in turn drives the price of the stock up even further. How often is Alaunos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Spruce Biosciences Short Interest Lantern Pharma Short Interest MediciNova Short Interest Rallybio Short Interest Celularity Short Interest Eledon Pharmaceuticals Short Interest Affimed Short Interest Checkpoint Therapeutics Short Interest Immix Biopharma Short Interest Theratechnologies Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCRT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.